Yi Qingqing 4
4 · BeiGene, Ltd. · Filed Jun 20, 2023
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Yi Qingqing
Director
Transactions
- Award
Share Option (Right to Buy)
2023-06-15+26,975→ 26,975 totalExercise: $16.41Exp: 2033-06-14→ Ordinary Shares (26,975 underlying) - Award
Ordinary Shares
2023-06-15+12,922→ 29,614 total
Footnotes (3)
- [F1]Represents securities underlying RSUs. All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.
- [F3]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.